baber/WOPTO huggingface dataset:
Patent DK-0405385-T3 (DK)
Inventor: NIELSEN THORKILD
IPC: A01C15/00
Filed: 1990-06-25
Granted: 1993-02-01
Abstract: An appliance for distribution of fertilizer. The appliance comprises a dump body (1) pivotally mounted in a frame (2) at the rear edge (3) of said dump body and arranged to empty successively fertilizer into a spreading aggregate (4) mounted in the frame (2). The feeding takes place by activation of the lifting-lowering cylinders (7) fastened to the bottom side of the dump body. The cylinders (7) are fastened to the frame (2) at the end facing away from the body (1). The frame (2) is carried by a chassis (5), which is supported by wheels, and between the frame (2) and the chassis (5) sensors (6) are placed arranged to register the force component transmitted between the frame (2) and the chassis (5). The cylinders (7) are preferably fastened to a cross member (8) extending between the ground and the bottom side of the chassis. In this manner an exact weighing and appropriate utilization of the standard cylinders (7) is achieved.
Patent DK-0482076-T3 (DK)
Inventor: PILLAI SUBRAMONIA
IPC: A61K39/10
Filed: 1990-07-16
Granted: 1995-07-17
Abstract: This invention pertains to interleukins-containing vaccine compositions, comprising a mixture of antigen and an adjuvant amount of an interleukin adsorbed onto a mineral in suspension and a preservative. Preferably, the mineral is alum. The interleukin can modulate the protective immune response to an antigen, while the mineral stabilizes the biological activity of the interleukin.
Patent DK-0457319-T3 (DK)
Inventor: HESSEL JOACHIM DR
IPC: F16L55/16
Filed: 1991-05-16
Granted: 1994-09-19
Abstract: A procedure which can be carried out easily for the connection of domestic outlet pipes to common sewers makes use of a special sealing sleeve (1), consisting of a tubular body (2) which is cylindrical externally and whose one side is closed by means of a thin elastic membrane (5), and on whose side opposite the membrane (5) there is fitted an outwardly projecting bead (4), and whose internal wall (3) forms essentially two stepped cones (15, 16), the wall thickness increasing towards the membrane. The domestic outlet pipe (6) is inserted into the common sewer together with the sealing sleeve (1) from the outside. The sealing sleeve (1) allows defective domestic outlet pipes to be repaired without major earthworks. 
<IMAGE>
Patent DK-0468430-T3 (DK)
Inventor: BOCK C RANDOLPH
IPC: A61N1/30
Filed: 1991-07-23
Granted: 1996-02-12
Abstract: A device for electrically assisted transport of molecules into the skin has a renewable power source and a means for electrically assisted transport of molecules in solution through the skin of an animal. The device has an anode (25) and a battery electrolyte (24) in fluid communication in a disposable part (12) of the means for electrically assisted transport of molecules in solution. The device has an air cathode (14) on a reusable part (11) of the means for electrically assisted transport so that when the reusable (11) and disposable (12) parts join, the battery electrolyte (24) and the air cathode (14) are in fluid communication. The power source is thereby renewed and electrically connected to the means for electrically assisted transport. A method for renewing and replenishing a power source for the device for electrically assisted transport of molecules in solution provides means for electrically assisted transport having a reusable part (11) and a disposable part (12). The method includes providing the reusable part (11) with an air cathode (14) and an anode contact on a support (13) and providing the disposable part (12) having an anode (25) in fluid communication with a battery electrolyte (24) on a carrier (21). The method renews the power source by joining the support (13) and the carrier (21). The battery electrolyte (24), the air cathode (14) and the anode (25) are thus joined in fluid communication and the anode (25) with the anode contact are electrically connected. <IMAGE>
Patent DK-0528582-T3 (DK)
Inventor: PEMAWANSA K P
IPC: B01D67/00
Filed: 1992-08-04
Granted: 1999-07-26
Abstract: The subject of this invention is a novel polymeric composition useful in membrane technology such as microfiltration, nanofiltration, ultrafiltration, reverse osmosis and gas separation. The composition is formed by taking a known condensation polymer such as polyether sulfone, polysulfone or a polyarylether sulfone and modifying it to change the molecular weight distribution. The useful polymers of the invention will have an unmodified number average molecular weight of about 63,000 or less and weight fraction of molecules with a molecular weight of 50,000 or less in the range of 30 to 35%. Utilizing fractional precipitation or other known techniques for concentrating a high molecular weight fraction of a polymer the polymers are modified to have a number average molecular weight of a least 59,000 or a weight fraction of molecules with a molecular weight of 50,000 or less of not more than 19%. Superior resistance to cracking and other forms of membrane degradation results from using the polymer compositions of the present invention in filtration applications.
Patent DK-0530111-T3 (DK)
Inventor: OHKUMA KAZUHIRO
IPC: A23L13/40
Filed: 1992-08-28
Granted: 1999-11-22
Abstract: An indigestible dextrin characterized in that the dextrin contains:       (A) up to 50% of 1-> 4 glycosidic linkages, and   (B) at least 60% of an indigestible component, (C) the content of indigestible component as actually determined varying within the range of +/-5% from a value Y calculated from at least one of equations, i.e., Equations 1 to 62, given in the specification, (D) the indigestible dextrin being prepared by adding hydrochloric acid to corn starch and heating the corn starch at 120 to 200 DEG C using an extruder, the value Y being a calculated content (%) of the indigestible component.
Patent DK-0569384-T3 (DK)
Inventor: CLOUGH JOHN MARTIN
IPC: C07D333/22
Filed: 1992-01-13
Granted: 1996-11-18
Abstract: Fungicidal compounds having the formula (I):    <IMAGE>  (I)  and stereoisomers thereof, wherein A is hydrogen, halo, hydroxy, C1-4 alkyl, C1-4 alkoxy, C1-4 haloalkyl, C1-4 haloalkoxy, C1-4 alkylcarbonyl, C1-4 alkoxycarbonyl, phenoxy, nitro or cyano; R1 and R2, which may be the same or different, are hydrogen, optionally substituted alkyl, optionally substituted cycloalkyl, optionally substituted heterocyclylalkyl, optionally substituted cycloalkylalkyl, optionally substituted aralkyl, optionally substituted aryloxyalkyl, optionally substituted heterocyclyloxyalkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted alkoxy, optionally substituted aryl, optionally substituted heterocyclyl, optionally substituted aryloxy, optionally substituted heterocyclyloxy, nitro halo cyano, -NR3R4, -CO2R3, -CONR3R4, -COR3, -S(O)nR3 wherein is 0, 1 or 2, (CH2)mPO(OR3)2 wherein m is 0 or 1, or R1 and R2 join to form a carbocyclic or heterocyclic ring system; R3 and R4, which are the same or different, are hydrogen, optionally substituted alkyl, optionally substituted aralkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted aryl or optionally substituted heteroaryl, or R3 and R4 join to form an optionally substituted heterocyclic ring; and R5 and R6 are independently hydrogen or C1-4 alkyl.
Patent DK-0582232-T3 (DK)
Inventor: BONA GIOACHINO
IPC: D04B1/20
Filed: 1993-07-30
Granted: 1998-01-19
Abstract: The prosthesis is manufactured by knitting a foundation yarn (1) and at least one effect yarn (2). The foundation yarn (1) has a high degree of heat-shrinkability while the effect yarn (2) is substantially heat stable. The structure thus obtained is then heated, for example by immersion in boiling water, so as to shrink the foundation yarn (1) and thereby reduce its permeability to liquids. The shrinking does not significantly affect the effect yarn (2). It is therefore possible to obtain good velvet effects without resorting to very high overfeed rates for the effect yarn (2). <IMAGE>
Patent DK-0625138-T3 (DK)
Inventor: ANDERSKEWITZ RALF
IPC: C07C315/04
Filed: 1993-01-14
Granted: 1999-11-15
Abstract: Amidine derivs. of formula (I), in the form of their racemates, enantiomer pure or enriched forms, diastereomer pairs, cis- and trans-isomers, free bases or salts (pref. with physiologically acceptable acids) are new. In (I), R1 and R2 are each CF3, halogen, R5, OR5, COR6, SR6, SOR6, SO2R6, SO2NR5R7, C(OH)R5R7, or R1 and R2 connect neighbouring C atoms on the benzene ring to which they are attached with -CR8=CR9CH=CH-, -CH=CR8CR9=CH-, -CR8=CHCR9=CH-, -OCHR10CH2-, -OCH2O-, -OCH2CH2O-, -(CH2)3-4-, -NHCOO-, -NHCOCH2O-, -COCH2O- or -COCH2CH2O-, each of these gps. being opt. substd. with 1-4C alkyl; R3 is H, OH, CF3, R5, OR6, COR6, CONR5R7, CH2OH, CH2O(1-4C alkyl), SR6, SOR6, SO2R6, SO2NR5R7, NHCO(1-4C alkyl), NHSO2(1-4C alkyl), NR5R7 or C(OH)R5R7 or a heterocyclic 5-ring contg. 1-3 heteroatoms and of formulae (a), (b) or (c); provided that if R3 is R5, R5 can only be H if at least one of R1 and R2 is not H; D, E and G are each CH, N, C(1-4C alkyl) or C-Ph; L is O or S; R4 is halogen, NH2, NH(1-4C alkyl), N(1-4C alkyl)2, OH, 1-4C alkoxy; R5 is H, 1-12C alkyl, phenyl(1-4C)alkyl or Ph (opt. substd. with halogen, 1-4C alkyl, 1-4C alkoxy or 2-5C acyl); R6 is 1-12C alkyl, Ph (opt. substd. with halogen, 1-4C alkyl, 1-4C alkoxy or 2-5C acyl); R7 is H or 1-12C alkyl; R8 and R9 are each H, OH, 1-4C alkyl, 1-4C alkoxy or 2-5C acyl; R10 is H or 1-4C alkyl; R11 and R12 are each H, OH, halogen, CF3, 1-4C alkyl or 1-4C alkoxy; A is (d), (e), X1A1X2, X2A2X3, X4A2X2, (CH2)1-2NHCO(CH2)1-3X2, -CH=CHA2X2; B is CH=CH, CH=N, S or (f); A1 is 2-4C alkylene, cis- or trans-CH2CH=CHCH2, CH2CCCH2, etc.; A2 is 1-5C alkylene; X1 is O, NH, S, SO, SO2, CO, CH2 or a gp. of formula (d); X2 is O, NH, S or a gp. of formula (e); X3 is NHCO, CONH, SO2NH or a gp. of formula (d); X4 is NHCO, CONH, NHSO2, SO2NH or NHCONH.
Patent DK-0598888-T3 (DK)
Inventor: CRISLER KENNETH J
IPC: H04B7/005
Filed: 1993-06-01
Granted: 2000-09-04
Abstract: A radio communication system controller embodies the present invention by providing extended use (306) of a communication resource (106) to a plurality of communication units. The inventive method includes the steps of assigning (402) a first communication resource to a first communication unit, and then temporarily configuring (406) the assigned communication resource as a reserved resource. The controller then receives (408), from a second communication unit, a request to transmit a second communication on the assigned communication resource. Lastly, the controller re-configures (412) the assigned communication resource to allow transmission of the second communication on the assigned communication resource.
Patent DK-0654034-T3 (DK)
Inventor: TURY BERNARD
IPC: C08G63/692
Filed: 1993-07-13
Granted: 1997-09-22
Abstract: PCT No. PCT/GB93/01464 Sec. 371 Date Apr. 18, 1995 Sec. 102(e) Date Apr. 18, 1995 PCT Filed Jul. 13, 1993 PCT Pub. No. WO94/03462 PCT Pub. Date Feb. 17, 1994Novel ammonium salts of organo-oxyphosphorus acids, organo-thiophosphorus acids and their esters and to the use thereof as additives for lubricants, especially for providing protection against extreme pressure and corrosion, to compositions containing these novel salts, a method for lubricating metal surfaces in frictional contact, and a metal surface treated with the salt or lubricant composition.
Patent DK-0631786-T3 (DK)
Inventor: EIBL JOHANN DR
IPC: A61P9/00
Filed: 1994-07-01
Granted: 1999-04-06
Abstract: A treatment of ischemia and the attendant reperfusion injury entails the administration plasmin and plasmin-forming proteins, including lys-plasminogen and similar substances. Lys-plasminogen, which can be obtained from the proteolytic cleavage of glu-plasminogen, has been found to have a protective effect on tissue that has been injured by ischemic conditions. The administration of lys-plasminogen can used to treat subjects during the time of reperfusion and after reperfusion has already occurred. Lys-plasminogen also can be administered in conjunction with clot lysis therapies, such as those that employ tissue plasminogen activator and the like. <IMAGE>
Patent DK-0637436-T3 (DK)
Inventor: SHARKEY HUGH R
IPC: A61B17/00
Filed: 1994-05-12
Granted: 2000-09-04
Abstract: A medical probe device comprising a catheter having a stylet guide housing with at least one stylet port in a side thereof and stylet guide means for directing a flexible stylet outward through at least one stylet port and through intervening tissue to targeted tissues. The stylet guide housing has an optical viewing means positioned for viewing the stylet and adjacent structure which includes a fiber optic channel means for receiving a fiber optic viewing device. The fiber optic channel means can include a guide port means for directing longitudinal movement of a fiber optic device with respect to the stylet guide means in a viewing zone and a flushing liquid channel in the stylet guide housing having an exit port positioned to direct flushing liquid issuing therefrom across the end of a fiber optic device when positioned in the viewing zone. The optical viewing means can comprise a viewing window positioned in the stylet guide housing for viewing the stylet when it is directed outward from its respective stylet port. The optical viewing means can include a fiber optic channel in the stylet guide housing for receiving the a fiber optic viewing device and aligning the viewing end thereof with the viewing window. Windowed devices can include a flushing liquid channel in the stylet guide housing having an exit port positioned to direct flushing liquid issuing therefrom across a surface of the viewing window. <IMAGE>
Patent DK-0614905-T3 (DK)
Inventor: AGOURIDAS CONSTANTIN
IPC: A61P31/04
Filed: 1994-03-08
Granted: 2000-03-06
Abstract: The subject of the invention is the compounds of formula (I) <IMAGE>  in which:     - X and Y represent a hydrogen atom or together form a radical: <IMAGE>     - R represents a radical: <IMAGE> in which m represents an integer between 0 and 20, n represents a number 0, 1, 2 or 3, XA = alkyl, alkenyl, alkynyl, Hal, C IDENTICAL N, NR1R2, OR3, COR4, CO2R5, SR6, <IMAGE>  SO2R8, <IMAGE>  aryl, heteroaryl, or OC(Ar)3 and   Z = H or an acid residue.   The compounds of formula (I) have antibiotic properties.
Patent DK-0683762-T3 (DK)
Inventor: KELNER MICHAEL J
IPC: A61K31/122
Filed: 1994-02-02
Granted: 1999-08-23
Abstract: A therapeutic method is provided to inhibit tumor cell growth in a subject in need of said therapy is provided, comprising parenterally administering a therapeutic amount of a compound in a pharmaceutically acceptable carrier, wherein said compound has the structure:    <IMAGE>   wherein R is selected from the group consisting of:    <IMAGE>     <IMAGE>   and wherein said tumor cell is sensitive to inhibition by said compound and is selected from the group consisting of a myeloid leukemia cell, a T-cell leukemia cell, a lung carcinoma cell, an ovarian carcinoma cell, and a breast carcinoma cell.
Patent DK-0727091-T3 (DK)
Inventor: HAMMERMAYER ERNST
IPC: H01C7/12
Filed: 1994-07-15
Granted: 1997-09-29
Abstract: An overvoltage protection device (2) has a plurality of varistors (51) fitted in a housing, whose earth electrodes are electrically interconnected via a strip (58). The mains electrodes (53) of the varistors are connected to contacts (34) via separators (60, 61). The separators consist of a push-rod in the form of a tubular rivet (60) connected to the electrodes (53) via a soft-soldered point (61). The push-rod (60) can move in a guide (100) of insulating material. One end of each push-rod (60) act together with a rocker (70) shared by all the separators which can pivot in the overvoltage protection device. On triggering, i.e. when one of the varistors (51) is overloaded, the soft-soldered connection (61) opens and the push-rod (60) concerned, actuated by a release spring (62), pivots the rocker (70) so that further switching operations are triggered. The rocker (70) also bears an indicating device (90, 91) visible through a window in the housing of the overvoltage protecting device (2), making it possible to see from outside that one of the separators (60, 61) has been triggered. As a single rocker (70) is allocated to all the separators, the design of the overvoltage protecting device is simple.
Patent DK-0698707-T3 (DK)
Inventor: BREINING RALF
IPC: E05B65/462
Filed: 1995-08-16
Granted: 2001-05-28
Abstract: The mechanism comprises two drive elements (7,14), each of which runs along a dimension of the tool trolley. One element (7) is horizontal and the other (14) is vertical. Both drive elements are so joined to each other that they must be moved together. For every object to be secured by a locking action, a locking hook (11,12,19,22) is arranged on one of the two drive elements. The drive elements take the form of displaceable bars (8,9,15) connected by a twin-armed lever (10).
Patent DK-0666577-T3 (DK)
Inventor: BRADBURY DAVID
IPC: B01J47/00
Filed: 1995-02-02
Granted: 2000-09-04
Abstract: Magnetic particles which comprise a core of a magnetic material surrounded by a mixture of a fibrous material and a solid binding agent. The particles may be embedded in a polymer resin which incorporates sites, which are selective for particular ions, to form composite magnetic resin particles. The composite magnetic resin particles may be used for the removal of pollutant ions from an aqueous solution in which they are contained.
Patent DK-0734106-T3 (DK)
Inventor: HASSE PETER DR-ING
IPC: H01T4/10
Filed: 1996-02-29
Granted: 2001-05-28
Abstract: The device has a pair of spark gaps (4, 6) connected in parallel circuit paths (1, 2). The second spark gap (6) has a higher response voltage threshold than the first spark gap (4), which is connected in series with an impedance (5). The overall voltage drop across the first spark gap and the impedance is greater than the response voltage threshold of the second spark gap, the latter pref. having a greater current conductivity and an electrode spacing (6c) which is between 5 and 10 times greater than the electrode spacing (4c) of the first spark gap.
Patent DK-0750024-T3 (DK)
Inventor: HAUBENNESTEL KARLHEINZ
IPC: C08J3/22
Filed: 1996-06-04
Granted: 2000-06-05
Abstract: This invention relates to free flowing additive preparations, particularly for powder coatings, which can be obtained by incorporating one or more liquid or viscous-adhesive additives in a wax melt consisting of one or more waxes, cooling the mixture obtained to a temperature below its melting point, and comminuting the solidified mixture or converting the mixture which is still liquid into a finely divided form and cooling the particles obtained. The invention also relates to a process for producing such preparations and to their use.
Patent DK-0831807-T3 (DK)
Inventor: HART CHARLES E
IPC: A61K31/122
Filed: 1996-06-04
Granted: 2006-05-08
Abstract: Methods for inhibiting intimal hyperplasia in the vasculature of mammals, including primates, are disclosed. The methods comprise administering to the mammal an effective amount of Brefeldin A or a derivative of Brefeldin A. The methods are useful in reducing intimal hyperplasia due to, for example, vascular injuries resulting from angioplasty, endarterectomy, reduction atherectomy or anastomosis of a vascular graft. The non-peptide PDGF antagonists Brefeldin A and its derivatives may optionally be administered coordinately with heparin, whereby the coordinately administered of non-peptide PDGF antagonist and heparin are combinatorially effective in inhibiting intimal hyperplasia.
Patent DK-0832873-T3 (DK)
Inventor: TURNBULL MICHAEL DRYSDALE
IPC: C07C69/743
Filed: 1994-05-25
Granted: 2006-07-03
Abstract: A process for the preparation of a lower alkyl ester of 3-(2-chloro-3,3,3-trifluoroprop-1-en-1-yl)- 2,2-dimethylcyclopropane carboxylic acid where lower alkyl means alkyl of up to four carbon atoms which comprises the steps of (a) reacting a compound of formula: CF3-CXCl-CH(OH)-CH=C(CH3)2 wherein X is chloro or bromo, with a tri-lower-alkyl orthoacetate containing up to four carbon atoms in each alkyl group in the presence of at least a catalytic amount of an active clay at an elevated temperature for a sufficient time to obtain a compound of formula: CF3-CXCl-CH=CH-C(CH3)2-CH2CO2R wherein R is an alkyl group containing up to four carbon atoms, and (b) treating said compound of formula (III) with at least one molar equivalent of a base to obtain said alkyl ester of 3-(2-chloro-3,3,3-trifluoroprop-1-en-1-yl)-2,2-dimethylcyclopropane carboxylic acid.
Patent DK-0959132-T3 (DK)
Inventor: YOKOTA SHOHEI
IPC: C12N9/48
Filed: 1997-10-13
Granted: 2006-12-11
Abstract: To provide a nucleic acid encoding a receptor protein kinase, wherein the nucleic acid has tandem duplication in a nucleotide sequence of a juxtamembrane and is useful for diagnosis of leukemia; a polypeptide encoded by the nucleic acid; an antibody capable of specifically binding to a region encoded by the nucleic acid having tandem duplication occurring in a nucleotide sequence of a juxtamembrane; a nucleic acid capable of specifically binding to the nucleic acid having tandem duplication occurring in a nucleotide sequence of a juxtamembrane; a method for detection of the nucleic acid encoding a receptor protein kinase; and a kit therefor. A nucleic acid encoding a receptor protein kinase, wherein the nucleic acid has tandem duplication in a nucleotide sequence of a juxtamembrane; a polypeptide encoded by the nucleic acid; an antibody capable of specifically binding to the portion of the polypeptide; a nucleic acid capable of specifically binding to the nucleic acid; a method for detection of the nucleic acid; and a kit for detection.
Patent DK-0971938-T3 (DK)
Inventor: KUBELA RUDOLF
IPC: C07F9/38
Filed: 1998-02-06
Granted: 2002-10-14
Abstract: A process is provided for the preparation of 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof which comprises of: a) reacting 4-aminobutyric acid with phosphorous acid and phosphorus trichloride in the presence of a polyalkylene(glycol); and b) recovering said 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof.
Patent DK-1011672-T3 (DK)
Inventor: MARTIN BILLY R
IPC: A61K31/505
Filed: 1998-08-07
Granted: 2006-02-06
Abstract: The present invention relates to treatment of pain with a new class of analgesic compounds. More particularly, the present invention relates to a method for reducing pain of a patient involving administering to a patient an effective amount of an aryl substituted olefinic amine compound. In one aspect, the inventive method of reducing pain in a patient involves use of metanicotine compounds as the analgesic agent.
Patent DK-0960710-T3 (DK)
Inventor: PLAMMER ALFRED
IPC: B29C43/46
Filed: 1999-04-27
Granted: 2003-11-17
Abstract: The product is released smoothly and without difficulty from the molds, paradoxically defeating its interlocking nature. The molds are formed in sections, being transverse strips, distributed around the circumference of a tempered calender roller. The strips move relatively: together to assemble the molds, and subsequently apart, to release the product. Preferred Features: The molding/extraction strips are constructed to move relative to the surface of the tempered cylinder on which they are carried. The required shape of the projection is machined-into the long sides of the strips, an arrangement facilitating trouble-free release. The molding shapes machined-in have head formations. These heads are conical or pyramidal. They are suitable for interlocked casting into flat concrete areas. The projections are alternatively rib profiles transverse to the direction of production. They are used similarly in casting, especially onto pipes or other curved concrete products.